MY135477A
(en )
2008-04-30
2-(2,6-dichlorophenyl)-diarylimidazoles
PH12013500123A1
(en )
2015-10-26
Hemiasterlin derivatives and uses thereof
MY136095A
(en )
2008-08-29
Use of human anti-ctla-4 antibodies for treatment of cancer
DE60112974D1
(en )
2005-09-29
Carbolinderivate
HK1080840A1
(en )
2006-05-04
Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
AU2002340168A1
(en )
2003-06-17
Treatment of prostate cancer by inhibitors of ncam2
BR0215360A
(en )
2004-12-14
Indoline derivatives useful as protein kinase inhibitors
HK1052940A1
(en )
2003-10-03
Synthetic methods for aplidine and new antitumoralderivatives, methods of making and using them
BR9912327A
(en )
2001-05-02
Urokinase inhibitors
HK1040983B
(en )
2005-09-16
Quinones for treatment of diseases
HK1068261A1
(en )
2005-04-29
Combinations comprisinga selective cyclooxygenase-2 inhibitor
AU2002367172A1
(en )
2003-07-15
2,4-diamino-pyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
GB2378948B
(en )
2004-11-10
Novel compounds for modulating cell proliferation
TR200101693T2
(en )
2002-06-21
Treatment of follicular lymphomas using inhibitors of the lysophoxin (LT) expression pathway.
PL357179A1
(en )
2004-07-26
Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
WO2002020000A3
(en )
2003-02-27
Combined estrogen blockade of the breast with exemestane and raloxifene
BRPI0415355A
(en )
2006-12-12
triarylimidazoles
HUP0300772A3
(en )
2005-11-28
Medicament for the immunotherapy of malignant tumours
UA49216A
(en )
2002-09-16
Remedy for treating complication following resection of malignant tumors of skin
AU2003236701A8
(en )
2003-12-22
Guanidino phenylalanin compounds used as urokinase inhibitors
MXPA02008014A
(en )
2004-04-05
Nitroacridine tumor inhibitor compositions.
AU2001256440A1
(en )
2001-11-12
Medicines for treating tumoral pathologies containing the ro5-4864 compound and an apoptosis-inducing agent
AU2002354738A1
(en )
2003-05-22
Xenogenic oligoor/and polyribonucleotides as agents for the treatment of malignant tumours
AU2002350513A1
(en )
2003-04-22
Use of solasonine for the treatment of skin tumors
IL159469A0
(en )
2004-06-01
Xenogenic oligo-or/and polyribonucleotides as agents for the treatment of malignant tumours